NCT00451243 Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment Status COMPLETED Phase N/A
NCT00432406 Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM) Status COMPLETED Phase PHASE3
NCT00317499 Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis Status COMPLETED Phase PHASE3
NCT00267956 An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT00245960 Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE3
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT00127842 REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) Status COMPLETED Phase PHASE4
NCT00051662 Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis Status COMPLETED Phase PHASE1
NCT00023205 Impact of Literacy Level on Patient Education and Health Among People With Arthritis Status COMPLETED Phase PHASE2